BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 19097588)

  • 1. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S; Hongsachart P; Sriyam S; Tantipaiboonwong P; Phutrakul S; Chen ST
    Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T; Carbone DP
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications.
    Fagerquist CK; Bates AH; Heath S; King BC; Garbus BR; Harden LA; Miller WG
    J Proteome Res; 2006 Oct; 5(10):2527-38. PubMed ID: 17022624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced detectability in proteome studies.
    Sriyam S; Sinchaikul S; Tantipaiboonwong P; Tzao C; Phutrakul S; Chen ST
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):91-104. PubMed ID: 17140866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical cancer proteomics: promises and pitfalls.
    Alaiya A; Al-Mohanna M; Linder S
    J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.
    Journet A; Ferro M
    Mass Spectrom Rev; 2004; 23(6):393-442. PubMed ID: 15290709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
    Hirano T; Kato H
    Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human saliva proteome analysis.
    Hu S; Loo JA; Wong DT
    Ann N Y Acad Sci; 2007 Mar; 1098():323-9. PubMed ID: 17435138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B; Ball G; Rees R
    Vaccine; 2007 Sep; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S; Byrum S; Siegel ER; Suva LJ
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic methodologies and their application in colorectal cancer research.
    Ikonomou G; Samiotaki M; Panayotou G
    Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
    Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
    Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
    Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
    Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
    Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics of lung cell biology and pulmonary disease.
    Levine SJ
    Expert Rev Respir Med; 2007 Oct; 1(2):255-69. PubMed ID: 20477189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.